enGene Therapeutics Inc. (ENGN) ROE
- 2026-04-30: ROE -49.71%.
- 2026-01-31: ROE -43.49%.
- 2025-10-31: ROE -69.94%.
- 2025-07-31: ROE -47.20%.
Complete source-backed roe history.
- Available history
- 2022-10-31 to 2026-04-30
- Data captured
Historical ROE
| Date | ROE |
|---|
| 2026-04-30 | -49.71% |
|---|
| 2026-01-31 | -43.49% |
|---|
| 2025-10-31 | -69.94% |
|---|
| 2025-07-31 | -47.20% |
|---|
| 2025-04-30 | -35.14% |
|---|
| 2025-01-31 | -27.62% |
|---|
| 2024-10-31 | -20.23% |
|---|
| 2024-07-31 | -53.12% |
|---|
| 2024-04-30 | -46.47% |
|---|
| 2024-01-31 | -165.44% |
|---|
| 2023-10-31 | -137.84% |
|---|
Annual ROE
| Date | ROE |
|---|
| 2025-10-31 | -69.94% |
|---|
| 2024-10-31 | -20.23% |
|---|
| 2023-10-31 | -137.84% |
|---|
| 2022-10-31 | 31.93% |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
|---|
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
|---|
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
|---|
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
|---|
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
|---|
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
|---|